Gemcit Injection 1 gm/26.3 ml is a sterile, ready-to-use intravenous formulation containing Gemcitabine, a potent chemotherapeutic agent widely used in the treatment of various cancers. Gemcitabine belongs to the class of nucleoside analogs and works by interfering with DNA synthesis, thereby inhibiting the growth and proliferation of cancer cells. Its effectiveness, combined with a manageable safety profile, makes it a preferred choice in oncology.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Gemcit Injection is primarily indicated for the treatment of:

• Pancreatic cancer – Often used as first-line therapy for locally advanced or metastatic pancreatic carcinoma.

• Non-small cell lung cancer (NSCLC) – Used alone or in combination with platinum-based agents for advanced stages.

• Breast cancer – For metastatic or locally advanced breast cancer, often in combination therapy.

• Ovarian cancer – Typically as part of combination chemotherapy regimens for recurrent or resistant cases.

• Other solid tumors – Investigational use in various malignancies as per clinical protocols.

Mechanism of Action

Gemcitabine is a deoxycytidine analog that incorporates into DNA during replication. Once incorporated, it inhibits DNA polymerase, preventing further chain elongation and triggering apoptosis (programmed cell death). Its unique action on the S-phase of the cell cycle enhances its efficacy against rapidly dividing cancer cells while sparing most normal cells.

Dosage and Administration

Gemcit Injection should be administered under strict medical supervision in a hospital or oncology clinic. Typical dosing involves intravenous infusion over 30–60 minutes. Dosage is calculated based on body surface area and adjusted according to:

• Patient’s hematologic status

• Renal and hepatic function

• Tolerance to previous chemotherapy cycles

It is essential to monitor blood counts, liver enzymes, and kidney function regularly to prevent adverse effects and ensure optimal therapeutic outcomes.

Precautions and Warnings

• Bone marrow suppression: Monitor for neutropenia, thrombocytopenia, and anemia.

• Infection risk: Patients should report fever, chills, or signs of infection immediately.

• Renal and hepatic impairment: Dose adjustments may be necessary.

• Pregnancy and lactation: Not recommended due to potential teratogenic effects.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include:

• Nausea and vomiting

• Fatigue and weakness

• Low blood cell counts (neutropenia, thrombocytopenia)

• Liver enzyme elevation

• Mild flu-like symptoms

Most side effects are manageable under medical supervision, and supportive care measures can help minimize discomfort.

Storage

Store Gemcit Injection 1 gm/26.3 ml in a cool, dry place at 2–8°C. Protect from light and do not freeze. Use immediately after preparation to maintain sterility and potency.

Conclusion

Gemcit Injection 1 gm/26.3 ml by SK Pharma is a highly effective chemotherapeutic solution that provides a reliable option for managing several advanced cancers. Its proven efficacy, combined with careful dosing and monitoring, ensures patients receive optimal therapeutic benefits with minimized risks.